Cargando…
Herbal medicine use for the management of COVID-19: A review article
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause pandemic of coronavirus disease 2019 (COVID-19). For many thousands of years, herbal products and dietary plants have been prescribed for various diseases by traditional healers. Thus, the aim of this review is to present main...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519661/ https://www.ncbi.nlm.nih.gov/pubmed/34693242 http://dx.doi.org/10.1016/j.metop.2021.100141 |
_version_ | 1784584494800437248 |
---|---|
author | Demeke, Chilot Abiyu Woldeyohanins, Alem Endashaw Kifle, Zemene Demelash |
author_facet | Demeke, Chilot Abiyu Woldeyohanins, Alem Endashaw Kifle, Zemene Demelash |
author_sort | Demeke, Chilot Abiyu |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause pandemic of coronavirus disease 2019 (COVID-19). For many thousands of years, herbal products and dietary plants have been prescribed for various diseases by traditional healers. Thus, the aim of this review is to present main herbal products, their source, characteristics, and potential antiviral actions concerning COVID-19. Publications on herbal products related to antiviral effects were searched from different databases, such as Web of Science, Google Scholar, Medline, Scopus, and PubMed, until August 2021, using English key terms. According to different studies, there are so many important medicinal plants with antiviral activity, which can be used for viral infections or can be prescribed as supportive treatment. lack of information on the safety profile and amount of dose for different diseases is some of the limitations of medicinal plants. herbal medicine can interfere with COVID-19 pathogenesis by inhibiting SARS-CoV-2 replication and entry to host cells. Some of the antiviral medicinal plant species are citrus Spp., orange (C. Sinensis), Allium sativum, Allium cepa, Mentha piperita, and nigella sativa are the most desirable herbal drink or fruit that can introduce effective adjuvant components in COVID-19 management. |
format | Online Article Text |
id | pubmed-8519661 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-85196612021-10-18 Herbal medicine use for the management of COVID-19: A review article Demeke, Chilot Abiyu Woldeyohanins, Alem Endashaw Kifle, Zemene Demelash Metabol Open Articles from the Vaccines, Immune Response, Therapeutic Interventions and COVID-19 Special Issue Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause pandemic of coronavirus disease 2019 (COVID-19). For many thousands of years, herbal products and dietary plants have been prescribed for various diseases by traditional healers. Thus, the aim of this review is to present main herbal products, their source, characteristics, and potential antiviral actions concerning COVID-19. Publications on herbal products related to antiviral effects were searched from different databases, such as Web of Science, Google Scholar, Medline, Scopus, and PubMed, until August 2021, using English key terms. According to different studies, there are so many important medicinal plants with antiviral activity, which can be used for viral infections or can be prescribed as supportive treatment. lack of information on the safety profile and amount of dose for different diseases is some of the limitations of medicinal plants. herbal medicine can interfere with COVID-19 pathogenesis by inhibiting SARS-CoV-2 replication and entry to host cells. Some of the antiviral medicinal plant species are citrus Spp., orange (C. Sinensis), Allium sativum, Allium cepa, Mentha piperita, and nigella sativa are the most desirable herbal drink or fruit that can introduce effective adjuvant components in COVID-19 management. Elsevier 2021-10-16 /pmc/articles/PMC8519661/ /pubmed/34693242 http://dx.doi.org/10.1016/j.metop.2021.100141 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles from the Vaccines, Immune Response, Therapeutic Interventions and COVID-19 Special Issue Demeke, Chilot Abiyu Woldeyohanins, Alem Endashaw Kifle, Zemene Demelash Herbal medicine use for the management of COVID-19: A review article |
title | Herbal medicine use for the management of COVID-19: A review article |
title_full | Herbal medicine use for the management of COVID-19: A review article |
title_fullStr | Herbal medicine use for the management of COVID-19: A review article |
title_full_unstemmed | Herbal medicine use for the management of COVID-19: A review article |
title_short | Herbal medicine use for the management of COVID-19: A review article |
title_sort | herbal medicine use for the management of covid-19: a review article |
topic | Articles from the Vaccines, Immune Response, Therapeutic Interventions and COVID-19 Special Issue |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519661/ https://www.ncbi.nlm.nih.gov/pubmed/34693242 http://dx.doi.org/10.1016/j.metop.2021.100141 |
work_keys_str_mv | AT demekechilotabiyu herbalmedicineuseforthemanagementofcovid19areviewarticle AT woldeyohaninsalemendashaw herbalmedicineuseforthemanagementofcovid19areviewarticle AT kiflezemenedemelash herbalmedicineuseforthemanagementofcovid19areviewarticle |